[Benefits and risks of gabapentinoids in geriatric psychiatry].

IF 1.1 4区 医学 Q4 CLINICAL NEUROLOGY
Maximilian Gahr
{"title":"[Benefits and risks of gabapentinoids in geriatric psychiatry].","authors":"Maximilian Gahr","doi":"10.1007/s00115-025-01850-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Gabapentinoids (gabapentin, pregabalin) are increasingly being prescribed and frequently in off-label indications. This applies also to older people.</p><p><strong>Objective: </strong>This article provides a current overview regarding the pharmacology, safety and tolerability and efficacy of gabapentinoids in psychogeriatric indications, particularly behavioral and psychological symptoms of dementia (BPSD).</p><p><strong>Material and methods: </strong>A selective literature search was carried out in the databases PubMed and ScienceDirect using the search terms \"gabapentin\", \"pregabalin\", \"dementia\" and \"elderly\".</p><p><strong>Results: </strong>The precise mechanism of action of the gabapentinoids is unclear but is based on inhibition of the α2δ subunits of presynaptic voltage-gated calcium channels. Rapid onset of action, principally good tolerability, negligible hepatic metabolization, low interaction potential and efficacy in relevant comorbid disorders such as epilepsy, neuropathic pain syndrome and anxiety disorders can be beneficial in gerontopsychiatric patients; however, in older patients there is an increased risk of falls and fractures, respiratory depression and pneumonia, cognitive and functional impairments and possibly atrial fibrillation. Regarding BPSD only one randomized controlled trial (RCT, pregabalin), systematic reviews and case series/case reports are available, predominantly reporting good efficacy and tolerability of gabapentinoids. In addition, a positive RCT (pregabalin) concerning generalized anxiety disorder (GAD) in older patients exists.</p><p><strong>Conclusion: </strong>Currently, sufficient evidence for a recommendation on gabapentinoids for the treatment of BPSD (or other off-label indications in geriatric psychiatry) or GAD in older patients is not available. In the case of insufficient efficacy of nonpharmacological interventions and substances with better evidence, gabapentinoids can be considered for the treatment of BPSD and GAD in older patients, particularly when the specific characteristics of gabapentinoids can be beneficial in a particular case; however, the specific risks should be considered.</p>","PeriodicalId":49770,"journal":{"name":"Nervenarzt","volume":" ","pages":""},"PeriodicalIF":1.1000,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nervenarzt","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00115-025-01850-6","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Gabapentinoids (gabapentin, pregabalin) are increasingly being prescribed and frequently in off-label indications. This applies also to older people.

Objective: This article provides a current overview regarding the pharmacology, safety and tolerability and efficacy of gabapentinoids in psychogeriatric indications, particularly behavioral and psychological symptoms of dementia (BPSD).

Material and methods: A selective literature search was carried out in the databases PubMed and ScienceDirect using the search terms "gabapentin", "pregabalin", "dementia" and "elderly".

Results: The precise mechanism of action of the gabapentinoids is unclear but is based on inhibition of the α2δ subunits of presynaptic voltage-gated calcium channels. Rapid onset of action, principally good tolerability, negligible hepatic metabolization, low interaction potential and efficacy in relevant comorbid disorders such as epilepsy, neuropathic pain syndrome and anxiety disorders can be beneficial in gerontopsychiatric patients; however, in older patients there is an increased risk of falls and fractures, respiratory depression and pneumonia, cognitive and functional impairments and possibly atrial fibrillation. Regarding BPSD only one randomized controlled trial (RCT, pregabalin), systematic reviews and case series/case reports are available, predominantly reporting good efficacy and tolerability of gabapentinoids. In addition, a positive RCT (pregabalin) concerning generalized anxiety disorder (GAD) in older patients exists.

Conclusion: Currently, sufficient evidence for a recommendation on gabapentinoids for the treatment of BPSD (or other off-label indications in geriatric psychiatry) or GAD in older patients is not available. In the case of insufficient efficacy of nonpharmacological interventions and substances with better evidence, gabapentinoids can be considered for the treatment of BPSD and GAD in older patients, particularly when the specific characteristics of gabapentinoids can be beneficial in a particular case; however, the specific risks should be considered.

[加巴喷丁在老年精神病学中的益处和风险]。
背景:加巴喷丁类药物(加巴喷丁、普瑞巴林)越来越多地被用于说明书外适应症。这也适用于老年人。目的:本文综述了加巴喷丁类药物在老年心理适应症,特别是痴呆(BPSD)的行为和心理症状中的药理学、安全性、耐受性和疗效。材料和方法:在PubMed和ScienceDirect数据库中使用检索词“gabapentin”、“pregabalin”、“dementia”和“elderly”进行选择性文献检索。结果:加巴喷丁类药物的确切作用机制尚不清楚,可能是基于对突触前电压门控钙通道α2δ亚基的抑制作用。快速起效,主要是良好的耐受性,可忽略肝脏代谢,低相互作用潜力和对相关合并症(如癫痫,神经性疼痛综合征和焦虑症)的疗效对老年精神病患者有益;然而,老年患者发生跌倒和骨折、呼吸抑制和肺炎、认知和功能障碍以及房颤的风险增加。关于BPSD,只有一项随机对照试验(RCT,普瑞巴林),系统评价和病例系列/病例报告,主要报告了加巴喷丁类药物的良好疗效和耐受性。此外,在老年患者中存在广泛性焦虑障碍(GAD)的阳性RCT(普瑞巴林)。结论:目前,没有足够的证据推荐加巴喷丁类药物治疗老年患者的BPSD(或其他老年精神病学的标签外适应症)或广泛性焦虑症。在非药物干预和有更好证据的物质效果不足的情况下,可以考虑加巴喷丁类药物治疗老年患者的BPSD和GAD,特别是当加巴喷丁类药物的特定特征在特定情况下可能有益时;但是,应该考虑具体的风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Nervenarzt
Nervenarzt 医学-精神病学
CiteScore
2.50
自引率
18.20%
发文量
169
审稿时长
4-8 weeks
期刊介绍: Der Nervenarzt is an internationally recognized journal addressing neurologists and psychiatrists working in clinical or practical environments. Essential findings and current information from neurology, psychiatry as well as neuropathology, neurosurgery up to psychotherapy are presented. Review articles provide an overview on selected topics and offer the reader a summary of current findings from all fields of neurology and psychiatry. Freely submitted original papers allow the presentation of important clinical studies and serve the scientific exchange. Review articles under the rubric ''Continuing Medical Education'' present verified results of scientific research and their integration into daily practice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信